...
首页> 外文期刊>Virology >A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus
【24h】

A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus

机译:一种新型嵌合新城疫病毒向量疫苗免受高病原禽流感病毒

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Avian influenza (AI) is an economically-important disease of poultry worldwide. The use of vaccines to control AI has increased because of frequent outbreaks of the disease in endemic countries. Newcastle disease virus (NDV) vectored vaccine has shown to be effective in protecting chickens against a highly pathogenic avian influenza virus (HPAIV) infection. However, preexisting antibodies to NDV vector might affect protective efficacy of the vaccine in the field. As an alternative strategy, we evaluated vaccine efficacy of a chimeric NDV vectored vaccine in which the ectodomains of F and HN proteins were replaced by those of avian paramyxovirus serotype-2. The chimeric NDV vector stably expressed the HA protein in vivo, did not cross-react with NDV, was attenuated to be used as a safe vaccine, and provided a partial protection of 1-day-old immunized chickens against HPAIV subtype H5N1challenge, indicating its potential use for early protection of chickens.
机译:禽流感(AI)是全球经济上重要的家禽疾病。 由于流行病国家的疾病频繁爆发,使用疫苗来控制ai增加。 染虫病毒(NDV)Vectored疫苗已显示有效保护鸡免受高致病性禽流感病毒(HPAIV)感染。 然而,预先存在于NDV载体的抗体可能影响疫苗在该领域的保护效果。 作为一种替代策略,我们评估了嵌合NDV矢量化疫苗的疫苗疗效,其中F和HN蛋白的胞外胚胎被禽副磷病毒血清型-2所取代。 嵌合的NDV载体稳定地表达体内HA蛋白,没有与NDV交叉反应,衰减以用作安全疫苗,并为HPAIV亚型H5N1Challenge提供了1天血免疫鸡的部分保护,表明其 潜在利用鸡的早期保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号